Scorpion Biological Services is an integrated contract research, and contract development and manufacturing organization (CDMO) focused on cell- and gene-based therapies and large molecule biologics. We will offer commercial-scale biomanufacturing in the coming years from our newly announced site in Manhattan, Kansas. We currently provide a broad array of clinical-scale biomanufacturing, analytical and R&D services to pharmaceutical and biotech companies from our San Antonio, Texas facilities. Scorpion is proud to focus on offering services using American equipment, reagents, and materials.
Clinical-Scale Biomanufacturing Facility
Scorpion is currently constructing a new clinical scale biologics manufacturing facility in San Antonio, Texas, scheduled to be operational in Q4 2022.